Author Question: When a fluid on one side of a cellular membrane contains a higher solute concentration than fluid on ... (Read 159 times)

berenicecastro

  • Hero Member
  • *****
  • Posts: 581
When a fluid on one side of a cellular membrane contains a higher solute concentration than fluid on the other side, the fluid is said to be:
 
  a. Hypertonic
  b. Isotonic
  c. Hypotonic
  d. Electrolytic

Question 2

The general shape of bones is:
 
  A) Short (bones are roughly equal in length and width).
  B) Irregular (bones have complex shapes).
  C) Long (bones are longer than they are wide).
  D) All of the above.



Danny Ewald

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

a
Rationale: a. Correct.
b. Isotonic implies that the fluids on either side are balanced.
c. Hypotonic implies that the fluid is less in solute concentration than fluid on the opposite side of the membrane.
d. Electrolytic does not pertain to body fluids.

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Your skin wrinkles if you stay in the bathtub a long time because the outermost layer of skin (which consists of dead keratin) swells when it absorbs water. It is tightly attached to the skin below it, so it compensates for the increased area by wrinkling. This happens to the hands and feet because they have the thickest layer of dead keratin cells.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library